Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples
(2019) In Scientific Reports 9(1). p.8777-8777- Abstract
Processing of complex cell preparations such as blood and peripheral blood progenitor cell (PBPC) transplants using label-free technologies is challenging. Transplant-contaminating neuroblastoma cells (NBCs) can contribute to relapse, and we therefore aimed to provide proof-of-principle evidence that label-free acoustophoretic separation can be applied for diagnostic NBC enrichment and removal ("purging") from human blood and PBPC products. Neuroblastoma cells spiked into blood and PBPC preparations served as model systems. Acoustophoresis enabled to enrich NBCs from mononuclear peripheral blood cells and PBPC samples with recovery rates of up to 60-97%. When aiming at high purity, NBC purities of up to 90% were realized, however,... (More)
Processing of complex cell preparations such as blood and peripheral blood progenitor cell (PBPC) transplants using label-free technologies is challenging. Transplant-contaminating neuroblastoma cells (NBCs) can contribute to relapse, and we therefore aimed to provide proof-of-principle evidence that label-free acoustophoretic separation can be applied for diagnostic NBC enrichment and removal ("purging") from human blood and PBPC products. Neuroblastoma cells spiked into blood and PBPC preparations served as model systems. Acoustophoresis enabled to enrich NBCs from mononuclear peripheral blood cells and PBPC samples with recovery rates of up to 60-97%. When aiming at high purity, NBC purities of up to 90% were realized, however, compromising recovery. Acoustophoretic purging of PBPC products allowed substantial tumour cell depletion of 1.5-2.3 log. PBPC loss under these conditions was considerable (>43%) but could be decreased to less than 10% while still achieving NBC depletion rates of 60-80%. Proliferation of cells was not affected by acoustic separation. These results provide first evidence that NBCs can be acoustically separated from blood and stem cell preparations with high recovery and purity, thus indicating that acoustophoresis is a promising technology for the development of future label-free, non-contact cell processing of complex cell products.
(Less)
- author
- Olm, Franziska LU ; Urbansky, Anke LU ; Dykes, Josefina H LU ; Laurell, Thomas LU and Scheding, Stefan LU
- organization
-
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- Bone marrow stem cells and cellular therapies (research group)
- Acoustofluidics group (research group)
- Division of Molecular Hematology (DMH)
- NanoLund: Centre for Nanoscience
- Department of Biomedical Engineering
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Division of Hematology and Transfusion Medicine
- MultiPark: Multidisciplinary research focused on Parkinson´s disease
- Stem Cell Center
- publishing date
- 2019-06-19
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scientific Reports
- volume
- 9
- issue
- 1
- pages
- 8777 - 8777
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85067822490
- pmid:31217534
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-019-45182-3
- language
- English
- LU publication?
- yes
- id
- 18ff7817-3f82-4875-bd16-2b594e221563
- date added to LUP
- 2019-07-02 11:09:49
- date last changed
- 2024-08-21 03:08:03
@article{18ff7817-3f82-4875-bd16-2b594e221563, abstract = {{<p>Processing of complex cell preparations such as blood and peripheral blood progenitor cell (PBPC) transplants using label-free technologies is challenging. Transplant-contaminating neuroblastoma cells (NBCs) can contribute to relapse, and we therefore aimed to provide proof-of-principle evidence that label-free acoustophoretic separation can be applied for diagnostic NBC enrichment and removal ("purging") from human blood and PBPC products. Neuroblastoma cells spiked into blood and PBPC preparations served as model systems. Acoustophoresis enabled to enrich NBCs from mononuclear peripheral blood cells and PBPC samples with recovery rates of up to 60-97%. When aiming at high purity, NBC purities of up to 90% were realized, however, compromising recovery. Acoustophoretic purging of PBPC products allowed substantial tumour cell depletion of 1.5-2.3 log. PBPC loss under these conditions was considerable (>43%) but could be decreased to less than 10% while still achieving NBC depletion rates of 60-80%. Proliferation of cells was not affected by acoustic separation. These results provide first evidence that NBCs can be acoustically separated from blood and stem cell preparations with high recovery and purity, thus indicating that acoustophoresis is a promising technology for the development of future label-free, non-contact cell processing of complex cell products.</p>}}, author = {{Olm, Franziska and Urbansky, Anke and Dykes, Josefina H and Laurell, Thomas and Scheding, Stefan}}, issn = {{2045-2322}}, language = {{eng}}, month = {{06}}, number = {{1}}, pages = {{8777--8777}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Label-free neuroblastoma cell separation from hematopoietic progenitor cell products using acoustophoresis - towards cell processing of complex biological samples}}, url = {{http://dx.doi.org/10.1038/s41598-019-45182-3}}, doi = {{10.1038/s41598-019-45182-3}}, volume = {{9}}, year = {{2019}}, }